CPhI Online

KOLINPHARMA® obtains the patent in the United States of America for IVUXUR® - 17/6/2019

2 Apr 2020

This is a further confirmation of the commitment of KOLINPHARMA® aimed at protecting and enhancing the know-how and investments made in R&D.

The obtaining of the patent, whose application had been filed at the end of 2015, will be valid on the US market until May 2036 and represents an important consolidation for the group's assets. A recognition that translates into a significant opportunity for the overseas extension of the product where the nutraceutical market recorded 23% growth in 2017 compared to 2014.

IVUXUR® is a food supplement, based on PACRAN® (dry cranberry extract), D-mannose, bearberry and zinc, intended to maintain the well-being of the urinary tract. It is a Kosher, Halal, Milk free, Doping Free certified product.

Read More